On January 23, 2020 Incyte (Nasdaq:INCY) reported that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020 (Press release, Incyte, JAN 23, 2020, View Source [SID1234553467]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The schedule for the press release and conference call/webcast is as follows:

Q4 & YE 2019 Press Release:
February 13, 2020 at 7:00 a.m. ET

Q4 & YE 2019 Conference Call:
February 13, 2020 at 8:00 a.m. ET

Domestic Dial-In Number:
877-407-3042

International Dial-In Number:
201-389-0864

Conference ID Number:
13698234

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13698234.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.